GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Price-to-Funds-From-Operations

Hansoh Pharmaceutical Group Co (HKSE:03692) Price-to-Funds-From-Operations : (As of Apr. 30, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Traded in Other Exchanges
Address
287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.